BioHealth News Archive
Prestigious annual pediatric medical device competition takes aim at congenital heart disease with five innovators sharing $150K in NCC-PDI grants · BioBuzz
Washington D.C., Dec. 10, 2021 (GLOBE NEWSWIRE) — The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces five awardees chosen in its prestigious annual “Make…
Read More
HHS Secretary Becerra Names Dr. Lawrence Tabak Acting Director of NIH | HHS.gov
Health and Human Services Secretary Xavier Becerra today announced that Lawrence A. Tabak, D.D.S., Ph.D., the principal deputy director of the National Institutes of…
Read More
WBJ – Novavax’s Campus Expansion Plans Earn Green Light in Gaithersburg
Novavax Inc. (NASDAQ: NVAX) just earned a critical approval to expand its Gaithersburg campus, paving the way for the homegrown biotech to exponentially grow its local…
Read More
CCP’s largest project awarded $204 million extension through July 2025 | Hub
The United States Agency for International Development has awarded a $204 million extension to the Johns Hopkins Center for Communication Programs to continue Breakthrough…
Read More
Global pandemic center will be in Rockville medical office building
A global center focusing on pandemic prevention and biodefense work will be in Rockville, county officials and partners in the project said Wednesday. Connected…
Read More
Harnessing the power of monoclonal antibodies in virology
Monoclonal antibodies have become one of humanity’s most powerful, multi-use tools in biology and medicine. Once the field of immunology established that they could…
Read More
Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the pre-exposure prophylaxis…
Read More
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
ROCKVILLE, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company focused on developing and commercializing products for the…
Read More
Montgomery County, MD Chosen for Global Pandemic Prevention and Biodefense Center Headquarters — MCEDC
Rockville, Md. — Montgomery County is home to the new Global Pandemic Prevention and Biodefense Center launched by Connected DMV. The Center will be co-located…
Read More
Time of day matters when getting COVID vaccine – Harvard Gazette
Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination. A new study published in the Journal…
Read More
IonQ Leads Charge for Quantum Commercialization at Q2B 2021
COLLEGE PARK, Md., December 07, 2021--(BUSINESS WIRE)--IonQ, Inc. ("IonQ") (NYSE: IONQ), a leader in trapped-ion quantum computing, today announced its participation at the fifth…
Read More
Where New Medical Devices Come From | by John G Younger | Bioeconomy.XYZ | Nov, 2021 | Medium
The transition from Angel to institutional funding is a key step (but not quite an absolute requirement) in the evolution of a start-up bringing…
Read More
Seed Funds | TEDCO
We work alongside our entrepreneurs as partners to drive the next wave of startups. We leverage our diverse operating and investing experience to uncover…
Read More
Innoforce Pharmaceuticals
Innoforce (“INF”), a biopharmaceutical manufacturing & development company, announced today the completion of a 1 billion CNY ($156.6M) Series A financing, with the closing of an…
Read More
Baltimore should be investing more in ‘wet labs’ | READER COMMENTARY
The critical shortage of “wet lab” space in Baltimore is an indictment of a city economic development strategy more concerned with real estate development…
Read More